Molecular tools for the pathologic diagnosis of central nervous system tumors
Files
Publication date
2019-02
Authors
Priesterbach-Ackley, L P
Wesseling, Pieter
Snijders, T. J.
de Vos, Filip Y F L
de Leng, Wendy W J
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Molecular diagnostics currently has a crucial role in neuro-oncological patient care. (Epi)genetic assays testing for point mutations, copy number variations, gene fusions, translocations, and methylation status are of main diagnostic interest in neuro-oncology. Multiple assays have been developed for this purpose, ranging from single gene tests to high-Throughput, integrated techniques enabling detection of multiple genetic aberrations in a single workflow. This review describes the nature of the simpler and more complex assays for molecular diagnostics of tumors of the central nervous system and briefly discusses their strengths and weaknesses.
Keywords
diagnosis, epigenetics, genetic alterations, molecular pathology, neuro-oncology, Taverne, Medicine (miscellaneous), Review, Journal Article
Citation
Priesterbach-Ackley, L P, Wesseling, P, Snijders, T J, De Vos, F Y F L & De Leng, W W J 2019, 'Molecular tools for the pathologic diagnosis of central nervous system tumors', Neuro-Oncology Practice, vol. 6, no. 1, pp. 4-16. https://doi.org/10.1093/nop/npy041